Azulfidine and Pancytopenia - a phase IV clinical study of FDA data
Pancytopenia is found among people who take Azulfidine, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Azulfidine and have Pancytopenia. It is created by eHealthMe based on reports of 7,443 people who have side effects when taking Azulfidine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
7,443 people reported to have side effects when taking Azulfidine.
Among them, 162 people (2.18%) have Pancytopenia.
What is Azulfidine?
Azulfidine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 7,543 Azulfidine users for its effectiveness, alternative drugs and more.
What is Pancytopenia?
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets) is found to be associated with 2,451 drugs and 2,330 conditions by eHealthMe.
Number of Azulfidine and Pancytopenia reports submitted per year:
Time on Azulfidine when people have Pancytopenia *:
Gender of people who have Pancytopenia when taking Azulfidine*:
Age of people who have Pancytopenia when taking Azulfidine *:
Common drugs people take besides Azulfidine *:
Common side effects people have besides Pancytopenia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Azulfidine and have Pancytopenia?Check whether Pancytopenia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
How severe was Pancytopenia and when was it recovered:
Expand to all the drugs that have ingredients of sulfasalazine:
- Pancytopenia and drugs with ingredients of sulfasalazine (302 reports)
Alternative drugs to, pros and cons of Azulfidine:
- Azulfidine (7,543 reports)
Common Azulfidine side effects:
Browse all side effects of Azulfidine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Pancytopenia treatments and more:
- Pancytopenia (61,604 reports)
COVID vaccines that are related to Pancytopenia:
- Pancytopenia in Moderna COVID Vaccine
- Pancytopenia in Pfizer BioNTech Covid Vaccine
- Pancytopenia in Johnson and Johnson Covid Vaccine
Common drugs associated with Pancytopenia:
All the drugs that are associated with Pancytopenia:
- Pancytopenia (2,451 drugs)
Common conditions associated with Pancytopenia:
All the conditions that are associated with Pancytopenia:
- Pancytopenia (2,330 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on sulfasalazine (the active ingredients of Azulfidine) and Azulfidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zocor and Injection Site Discoloration - a second ago
- Tafinlar and Systemic Lupus Erythematosus - 2 seconds ago
- Hydrochlorothiazide and Diabetes Mellitus Inadequate Control - 4 seconds ago
- Avalide and Ramipril drug interaction - 6 seconds ago
- Paxil and Cryoglobulins Present - 9 seconds ago
- Gleostine and Thrombocytopenia Aggravated - 12 seconds ago
- Actiq and Gastroenteritis Viral - 19 seconds ago
- Sinusitis and Jaundice - Yellow Skin - 27 seconds ago
- Ceftriaxone and Neutrophil Percentage Increased - 30 seconds ago
- Zoloft and Gastric Hypermotility - 31 seconds ago